Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ensomafusp alfa by F. Hoffmann-La Roche for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Ensomafusp alfa is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Diffuse Large B-Cell Lymphoma....
Ensomafusp alfa by F. Hoffmann-La Roche for Marginal Zone B-cell Lymphoma: Likelihood of Approval
Ensomafusp alfa is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Marginal Zone B-cell Lymphoma....
Ensomafusp alfa by F. Hoffmann-La Roche for Follicular Lymphoma: Likelihood of Approval
Ensomafusp alfa is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Follicular Lymphoma. According to...
Ensomafusp alfa by F. Hoffmann-La Roche for Mantle Cell Lymphoma: Likelihood of Approval
Ensomafusp alfa is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Mantle Cell Lymphoma. According...